ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -95.2% | 600 | -96.5% | 0.00% | – |
| Q3 2018 | $63,000 | – | 17,239 | +9584.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 178 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $103,000 | +930.0% | 27,963 | +669.7% | 0.01% | – |
| Q4 2017 | $10,000 | +900.0% | 3,633 | +742.9% | 0.00% | – |
| Q3 2017 | $1,000 | -92.3% | 431 | -86.8% | 0.00% | -100.0% |
| Q1 2017 | $13,000 | -95.0% | 3,271 | -89.9% | 0.00% | -94.4% |
| Q3 2016 | $262,000 | +98.5% | 32,439 | +90.7% | 0.02% | +100.0% |
| Q2 2016 | $132,000 | +193.3% | 17,009 | +188.6% | 0.01% | +125.0% |
| Q1 2016 | $45,000 | -85.0% | 5,893 | -78.8% | 0.00% | -82.6% |
| Q4 2015 | $300,000 | +3650.0% | 27,853 | +2742.1% | 0.02% | +2200.0% |
| Q2 2015 | $8,000 | -92.5% | 980 | -91.0% | 0.00% | -91.7% |
| Q1 2015 | $106,000 | -48.3% | 10,832 | -35.4% | 0.01% | -52.0% |
| Q4 2014 | $205,000 | – | 16,766 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
| RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
| DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
| Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
| TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
| Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
| Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
| SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
| Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |